Report Scope & Overview:
Executive Summary:
The global Drug-Eluting Stent market is expected to experience significant growth due to various factors such as increasing demand for the product, the presence of key market players, and advancements in technology. This report provides an in-depth analysis of the market size, growth trends, pricing structure, production, value chain analysis, and regional assessment. The report also offers insights into company profiling and emerging product lines.
Global Drug-Eluting Stent Market: By Company
• Boston Scientific
• Medtronic
• Abbott
• Lepu Medical
• B. Braun Melsungen
• MicroPort Scientific
• Cook Medical
• Terumo
• Biosensors International
• Balton
• AlviMedica Medical Technologies
• Biotronik
• Shandong JW Medical
• Sino Medical
• Beijing AMSINO
Global Drug-Eluting Stent Market: By Type
• Rapamycin Eluting Stent
• Paclitaxel Eluting Stent
• Everolimus Eluting Stent
• Others
Global Drug-Eluting Stent Market: By Application
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others
Global Drug-Eluting Stent Market: Regional Analysis
The regional analysis of the global Drug-Eluting Stent market provides insights into the market's performance across different regions of the world. The analysis is based on recent and future trends and includes market forecast for the prediction period. The countries covered in the regional analysis of the Drug-Eluting Stent market report are as follows:
North America: The North America region includes the U.S., Canada, and Mexico. The U.S. is the largest market for Drug-Eluting Stent in this region, followed by Canada and Mexico. The market growth in this region is primarily driven by the presence of key market players and the increasing demand for the product.
Europe: The Europe region includes Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe. Germany is the largest market for Drug-Eluting Stent in this region, followed by the U.K. and France. The market growth in this region is driven by the increasing demand for the product in the automotive and aerospace sectors.
Asia-Pacific: The Asia-Pacific region includes Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, and Rest of Asia-Pacific. China is the largest market for Drug-Eluting Stent in this region, followed by Japan and India. The market growth in this region is driven by the increasing adoption of the product in various end-use industries, such as automotive, aerospace, and construction.
Middle East and Africa: The Middle East and Africa region includes Saudi Arabia, U.A.E, South Africa, Egypt, Israel, and Rest of Middle East and Africa. The market growth in this region is driven by the increasing demand for the product in the aerospace and defense sectors.
South America: The South America region includes Argentina, Brazil, and Rest of South America. Brazil is the largest market for Drug-Eluting Stent in this region, followed by Argentina. The market growth in this region is primarily driven by the increasing demand for the product in the automotive sector.
Reasons to Purchase Drug-Eluting Stent Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies
Objectives of Drug-Eluting Stent Market Study:
The objectives of Drug-Eluting Stent market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of Drug-Eluting Stent market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
The global Drug-Eluting Stent market is expected to experience significant growth due to various factors such as increasing demand for the product, the presence of key market players, and advancements in technology. This report provides an in-depth analysis of the market size, growth trends, pricing structure, production, value chain analysis, and regional assessment. The report also offers insights into company profiling and emerging product lines.
Overview: A drug-eluting stent is a medical device used in interventional cardiology to treat coronary artery disease. It is a stent (a small mesh tube) coated with a medication that is slowly released into the surrounding tissue to prevent the re-narrowing of the coronary artery after it has been opened through angioplasty.
Market Drivers:
Prevention of Restenosis: Drug-eluting stents are designed to reduce the occurrence of restenosis, which is the re-narrowing of the treated coronary artery after angioplasty. The drug coating helps inhibit tissue overgrowth.
Technological Advancements: Continuous advancements in stent design, drug coatings, and delivery systems contribute to improved efficacy and safety of drug-eluting stents.
Increasing Cardiovascular Diseases: The rising prevalence of cardiovascular diseases globally, including coronary artery disease, drives the demand for effective interventional cardiology solutions like drug-eluting stents.
Aging Population: The aging population is more susceptible to cardiovascular diseases, leading to an increased need for interventions such as stent implantation.
Market Challenges:
Long-Term Safety Concerns: There have been concerns related to the long-term safety of drug-eluting stents, particularly regarding late thrombosis and the need for prolonged dual antiplatelet therapy.
Competitive Landscape: The drug-eluting stent market is competitive, with multiple players striving to introduce innovative products, making it challenging for individual manufacturers to maintain a dominant position.
Market Trends:
Biodegradable Coatings: The development of stents with biodegradable coatings aims to address concerns related to long-term safety by allowing the gradual absorption of the coating over time.
Drug-Device Combinations: Integration of advanced drug formulations with stent technology continues to evolve, offering enhanced therapeutic effects.
Patient-Specific Approaches: Tailoring drug-eluting stent treatments based on patient characteristics and genetic factors is an emerging trend.
Global Drug-Eluting Stent Market: By Company
• Boston Scientific
• Medtronic
• Abbott
• Lepu Medical
• B. Braun Melsungen
• MicroPort Scientific
• Cook Medical
• Terumo
• Biosensors International
• Balton
• AlviMedica Medical Technologies
• Biotronik
• Shandong JW Medical
• Sino Medical
• Beijing AMSINO
Global Drug-Eluting Stent Market: By Type
• Rapamycin Eluting Stent
• Paclitaxel Eluting Stent
• Everolimus Eluting Stent
• Others
Global Drug-Eluting Stent Market: By Application
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others
Global Drug-Eluting Stent Market: Regional Analysis
The regional analysis of the global Drug-Eluting Stent market provides insights into the market's performance across different regions of the world. The analysis is based on recent and future trends and includes market forecast for the prediction period. The countries covered in the regional analysis of the Drug-Eluting Stent market report are as follows:
North America: The North America region includes the U.S., Canada, and Mexico. The U.S. is the largest market for Drug-Eluting Stent in this region, followed by Canada and Mexico. The market growth in this region is primarily driven by the presence of key market players and the increasing demand for the product.
Europe: The Europe region includes Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe. Germany is the largest market for Drug-Eluting Stent in this region, followed by the U.K. and France. The market growth in this region is driven by the increasing demand for the product in the automotive and aerospace sectors.
Asia-Pacific: The Asia-Pacific region includes Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, and Rest of Asia-Pacific. China is the largest market for Drug-Eluting Stent in this region, followed by Japan and India. The market growth in this region is driven by the increasing adoption of the product in various end-use industries, such as automotive, aerospace, and construction.
Middle East and Africa: The Middle East and Africa region includes Saudi Arabia, U.A.E, South Africa, Egypt, Israel, and Rest of Middle East and Africa. The market growth in this region is driven by the increasing demand for the product in the aerospace and defense sectors.
South America: The South America region includes Argentina, Brazil, and Rest of South America. Brazil is the largest market for Drug-Eluting Stent in this region, followed by Argentina. The market growth in this region is primarily driven by the increasing demand for the product in the automotive sector.
| Report Attribute/Metric | Details |
| Base Year | 2022 |
| Forecast Period | 2023-2032 |
| Historical Data | 2018-2022 |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| By Type | • Rapamycin Eluting Stent • Paclitaxel Eluting Stent • Everolimus Eluting Stent |
| By Application | • Hospitals • Clinics • Ambulatory Surgical Centers |
| Key Companies Profiled | • Boston Scientific • Medtronic • Abbott • Lepu Medical • B. Braun Melsungen • MicroPort Scientific • Cook Medical • Terumo • Biosensors International • Balton • AlviMedica Medical Technologies • Biotronik • Shandong JW Medical • Sino Medical • Beijing AMSINO |
| Regions and Key Countries Covered | U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America |
| Customization Scope | Available on Request |
Reasons to Purchase Drug-Eluting Stent Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies
Objectives of Drug-Eluting Stent Market Study:
The objectives of Drug-Eluting Stent market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of Drug-Eluting Stent market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Frequently Asked Questions
Regulatory approval processes, adherence to safety standards, and post-market surveillance are critical factors influencing the drug-eluting stent market.
North America and Europe are the major contributors to the drug-eluting stent market, with Asia-Pacific showing significant growth potential.
The increasing prevalence of cardiovascular diseases, advancements in stent technologies, and a growing aging population are driving the demand for drug-eluting stents.
Key players in the drug-eluting stent market include Boston Scientific, Medtronic, Abbott, Lepu Medical, B. Braun Melsungen, MicroPort Scientific, Cook Medical, Terumo, Biosensors International, Balton, AlviMedica Medical Technologies, Biotronik, Shandong JW Medical, Sino Medical, Beijing AMSINO
Innovations such as bioresorbable stents, drug-eluting stents with biodegradable polymers, and advancements in drug formulations are shaping the market.
TABLE OF CONTENT
1 Drug-Eluting Stent Market Overview
1.1 Product Overview and Scope of Drug-Eluting Stent
1.2 Drug-Eluting Stent Segment by Type
1.2.1 Global Drug-Eluting Stent Market Value Comparison by Type (2023-2029)
1.2.2 Rapamycin Eluting Stent
1.2.3 Paclitaxel Eluting Stent
1.2.4 Everolimus Eluting Stent
1.2.5 Others
1.3 Drug-Eluting Stent Segment by Application
1.3.1 Global Drug-Eluting Stent Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Global Drug-Eluting Stent Market Size Estimates and Forecasts
1.4.1 Global Drug-Eluting Stent Revenue 2018-2029
1.4.2 Global Drug-Eluting Stent Sales 2018-2029
1.4.3 Global Drug-Eluting Stent Market Average Price (2017-2032)
1.5 Assumptions and Limitations
2 Drug-Eluting Stent Market Competition by Manufacturers
2.1 Global Drug-Eluting Stent Sales Market Share by Manufacturers (2017-2023)
2.2 Global Drug-Eluting Stent Revenue Market Share by Manufacturers (2017-2023)
2.3 Global Drug-Eluting Stent Average Price by Manufacturers (2017-2023)
2.4 Global Drug-Eluting Stent Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Drug-Eluting Stent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug-Eluting Stent, Product Type & Application
2.7 Drug-Eluting Stent Market Competitive Situation and Trends
2.7.1 Drug-Eluting Stent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drug-Eluting Stent Players Market Share by Revenue
2.7.3 Global Drug-Eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug-Eluting Stent Retrospective Market Scenario by Region
3.1 Global Drug-Eluting Stent Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Drug-Eluting Stent Global Drug-Eluting Stent Sales by Region: 2018-2029
3.2.1 Global Drug-Eluting Stent Sales by Region: 2018-2023
3.2.2 Global Drug-Eluting Stent Sales by Region: 2024-2029
3.3 Global Drug-Eluting Stent Global Drug-Eluting Stent Revenue by Region: 2018-2029
3.3.1 Global Drug-Eluting Stent Revenue by Region: 2018-2023
3.3.2 Global Drug-Eluting Stent Revenue by Region: 2024-2029
3.4 North America Drug-Eluting Stent Market Facts & Figures by Country
3.4.1 North America Drug-Eluting Stent Market Size by Country: 2018 VS 2023 VS 2032
3.4.2 North America Drug-Eluting Stent Sales by Country (2017-2032)
3.4.3 North America Drug-Eluting Stent Revenue by Country (2017-2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Drug-Eluting Stent Market Facts & Figures by Country
3.5.1 Europe Drug-Eluting Stent Market Size by Country: 2018 VS 2023 VS 2032
3.5.2 Europe Drug-Eluting Stent Sales by Country (2017-2032)
3.5.3 Europe Drug-Eluting Stent Revenue by Country (2017-2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug-Eluting Stent Market Facts & Figures by Country
3.6.1 Asia Pacific Drug-Eluting Stent Market Size by Country: 2018 VS 2023 VS 2032
3.6.2 Asia Pacific Drug-Eluting Stent Sales by Country (2017-2032)
3.6.3 Asia Pacific Drug-Eluting Stent Revenue by Country (2017-2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Drug-Eluting Stent Market Facts & Figures by Country
3.7.1 Latin America Drug-Eluting Stent Market Size by Country: 2018 VS 2023 VS 2032
3.7.2 Latin America Drug-Eluting Stent Sales by Country (2017-2032)
3.7.3 Latin America Drug-Eluting Stent Revenue by Country (2017-2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug-Eluting Stent Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug-Eluting Stent Market Size by Country: 2018 VS 2023 VS 2032
3.8.2 Middle East and Africa Drug-Eluting Stent Sales by Country (2017-2032)
3.8.3 Middle East and Africa Drug-Eluting Stent Revenue by Country (2017-2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug-Eluting Stent Sales by Type (2017-2032)
4.1.1 Global Drug-Eluting Stent Sales by Type (2017-2023)
4.1.2 Global Drug-Eluting Stent Sales by Type (2023-2032)
4.1.3 Global Drug-Eluting Stent Sales Market Share by Type (2017-2032)
4.2 Global Drug-Eluting Stent Revenue by Type (2017-2032)
4.2.1 Global Drug-Eluting Stent Revenue by Type (2017-2023)
4.2.2 Global Drug-Eluting Stent Revenue by Type (2023-2032)
4.2.3 Global Drug-Eluting Stent Revenue Market Share by Type (2017-2032)
4.3 Global Drug-Eluting Stent Price by Type (2017-2032)
5 Segment by Application
5.1 Global Drug-Eluting Stent Sales by Application (2017-2032)
5.1.1 Global Drug-Eluting Stent Sales by Application (2017-2023)
5.1.2 Global Drug-Eluting Stent Sales by Application (2023-2032)
5.1.3 Global Drug-Eluting Stent Sales Market Share by Application (2017-2032)
5.2 Global Drug-Eluting Stent Revenue by Application (2017-2032)
5.2.1 Global Drug-Eluting Stent Revenue by Application (2017-2023)
5.2.2 Global Drug-Eluting Stent Revenue by Application (2023-2032)
5.2.3 Global Drug-Eluting Stent Revenue Market Share by Application (2017-2032)
5.3 Global Drug-Eluting Stent Price by Application (2017-2032)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Corporation Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.1.4 Boston Scientific Drug-Eluting Stent Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.2.4 Medtronic Drug-Eluting Stent Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.3.4 Abbott Drug-Eluting Stent Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Lepu Medical
6.4.1 Lepu Medical Corporation Information
6.4.2 Lepu Medical Description and Business Overview
6.4.3 Lepu Medical Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Lepu Medical Drug-Eluting Stent Product Portfolio
6.4.5 Lepu Medical Recent Developments/Updates
6.5 B. Braun Melsungen
6.5.1 B. Braun Melsungen Corporation Information
6.5.2 B. Braun Melsungen Description and Business Overview
6.5.3 B. Braun Melsungen Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.5.4 B. Braun Melsungen Drug-Eluting Stent Product Portfolio
6.5.5 B. Braun Melsungen Recent Developments/Updates
6.6 MicroPort Scientific
6.6.1 MicroPort Scientific Corporation Information
6.6.2 MicroPort Scientific Description and Business Overview
6.6.3 MicroPort Scientific Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.6.4 MicroPort Scientific Drug-Eluting Stent Product Portfolio
6.6.5 MicroPort Scientific Recent Developments/Updates
6.7 Cook Medical
6.6.1 Cook Medical Corporation Information
6.6.2 Cook Medical Description and Business Overview
6.6.3 Cook Medical Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Cook Medical Drug-Eluting Stent Product Portfolio
6.7.5 Cook Medical Recent Developments/Updates
6.8 Terumo
6.8.1 Terumo Corporation Information
6.8.2 Terumo Description and Business Overview
6.8.3 Terumo Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.8.4 Terumo Drug-Eluting Stent Product Portfolio
6.8.5 Terumo Recent Developments/Updates
6.9 Biosensors International
6.9.1 Biosensors International Corporation Information
6.9.2 Biosensors International Description and Business Overview
6.9.3 Biosensors International Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.9.4 Biosensors International Drug-Eluting Stent Product Portfolio
6.9.5 Biosensors International Recent Developments/Updates
6.10 Balton
6.10.1 Balton Corporation Information
6.10.2 Balton Description and Business Overview
6.10.3 Balton Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.10.4 Balton Drug-Eluting Stent Product Portfolio
6.10.5 Balton Recent Developments/Updates
6.11 AlviMedica Medical Technologies
6.11.1 AlviMedica Medical Technologies Corporation Information
6.11.2 AlviMedica Medical Technologies Drug-Eluting Stent Description and Business Overview
6.11.3 AlviMedica Medical Technologies Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.11.4 AlviMedica Medical Technologies Drug-Eluting Stent Product Portfolio
6.11.5 AlviMedica Medical Technologies Recent Developments/Updates
6.12 Biotronik
6.12.1 Biotronik Corporation Information
6.12.2 Biotronik Drug-Eluting Stent Description and Business Overview
6.12.3 Biotronik Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.12.4 Biotronik Drug-Eluting Stent Product Portfolio
6.12.5 Biotronik Recent Developments/Updates
6.13 Shandong JW Medical
6.13.1 Shandong JW Medical Corporation Information
6.13.2 Shandong JW Medical Drug-Eluting Stent Description and Business Overview
6.13.3 Shandong JW Medical Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.13.4 Shandong JW Medical Drug-Eluting Stent Product Portfolio
6.13.5 Shandong JW Medical Recent Developments/Updates
6.14 Sino Medical
6.14.1 Sino Medical Corporation Information
6.14.2 Sino Medical Drug-Eluting Stent Description and Business Overview
6.14.3 Sino Medical Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.14.4 Sino Medical Drug-Eluting Stent Product Portfolio
6.14.5 Sino Medical Recent Developments/Updates
6.15 Beijing AMSINO
6.15.1 Beijing AMSINO Corporation Information
6.15.2 Beijing AMSINO Drug-Eluting Stent Description and Business Overview
6.15.3 Beijing AMSINO Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.15.4 Beijing AMSINO Drug-Eluting Stent Product Portfolio
6.15.5 Beijing AMSINO Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug-Eluting Stent Industry Chain Analysis
7.2 Drug-Eluting Stent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug-Eluting Stent Production Mode & Process
7.4 Drug-Eluting Stent Sales and Marketing
7.4.1 Drug-Eluting Stent Sales Channels
7.4.2 Drug-Eluting Stent Distributors
7.5 Drug-Eluting Stent Customers
8 Drug-Eluting Stent Market Dynamics
8.1 Drug-Eluting Stent Industry Trends
8.2 Drug-Eluting Stent Market Drivers
8.3 Drug-Eluting Stent Market Challenges
8.4 Drug-Eluting Stent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Drug-Eluting Stent
1.2 Drug-Eluting Stent Segment by Type
1.2.1 Global Drug-Eluting Stent Market Value Comparison by Type (2023-2029)
1.2.2 Rapamycin Eluting Stent
1.2.3 Paclitaxel Eluting Stent
1.2.4 Everolimus Eluting Stent
1.2.5 Others
1.3 Drug-Eluting Stent Segment by Application
1.3.1 Global Drug-Eluting Stent Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Global Drug-Eluting Stent Market Size Estimates and Forecasts
1.4.1 Global Drug-Eluting Stent Revenue 2018-2029
1.4.2 Global Drug-Eluting Stent Sales 2018-2029
1.4.3 Global Drug-Eluting Stent Market Average Price (2017-2032)
1.5 Assumptions and Limitations
2 Drug-Eluting Stent Market Competition by Manufacturers
2.1 Global Drug-Eluting Stent Sales Market Share by Manufacturers (2017-2023)
2.2 Global Drug-Eluting Stent Revenue Market Share by Manufacturers (2017-2023)
2.3 Global Drug-Eluting Stent Average Price by Manufacturers (2017-2023)
2.4 Global Drug-Eluting Stent Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Drug-Eluting Stent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug-Eluting Stent, Product Type & Application
2.7 Drug-Eluting Stent Market Competitive Situation and Trends
2.7.1 Drug-Eluting Stent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drug-Eluting Stent Players Market Share by Revenue
2.7.3 Global Drug-Eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug-Eluting Stent Retrospective Market Scenario by Region
3.1 Global Drug-Eluting Stent Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Drug-Eluting Stent Global Drug-Eluting Stent Sales by Region: 2018-2029
3.2.1 Global Drug-Eluting Stent Sales by Region: 2018-2023
3.2.2 Global Drug-Eluting Stent Sales by Region: 2024-2029
3.3 Global Drug-Eluting Stent Global Drug-Eluting Stent Revenue by Region: 2018-2029
3.3.1 Global Drug-Eluting Stent Revenue by Region: 2018-2023
3.3.2 Global Drug-Eluting Stent Revenue by Region: 2024-2029
3.4 North America Drug-Eluting Stent Market Facts & Figures by Country
3.4.1 North America Drug-Eluting Stent Market Size by Country: 2018 VS 2023 VS 2032
3.4.2 North America Drug-Eluting Stent Sales by Country (2017-2032)
3.4.3 North America Drug-Eluting Stent Revenue by Country (2017-2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Drug-Eluting Stent Market Facts & Figures by Country
3.5.1 Europe Drug-Eluting Stent Market Size by Country: 2018 VS 2023 VS 2032
3.5.2 Europe Drug-Eluting Stent Sales by Country (2017-2032)
3.5.3 Europe Drug-Eluting Stent Revenue by Country (2017-2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug-Eluting Stent Market Facts & Figures by Country
3.6.1 Asia Pacific Drug-Eluting Stent Market Size by Country: 2018 VS 2023 VS 2032
3.6.2 Asia Pacific Drug-Eluting Stent Sales by Country (2017-2032)
3.6.3 Asia Pacific Drug-Eluting Stent Revenue by Country (2017-2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Drug-Eluting Stent Market Facts & Figures by Country
3.7.1 Latin America Drug-Eluting Stent Market Size by Country: 2018 VS 2023 VS 2032
3.7.2 Latin America Drug-Eluting Stent Sales by Country (2017-2032)
3.7.3 Latin America Drug-Eluting Stent Revenue by Country (2017-2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug-Eluting Stent Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug-Eluting Stent Market Size by Country: 2018 VS 2023 VS 2032
3.8.2 Middle East and Africa Drug-Eluting Stent Sales by Country (2017-2032)
3.8.3 Middle East and Africa Drug-Eluting Stent Revenue by Country (2017-2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug-Eluting Stent Sales by Type (2017-2032)
4.1.1 Global Drug-Eluting Stent Sales by Type (2017-2023)
4.1.2 Global Drug-Eluting Stent Sales by Type (2023-2032)
4.1.3 Global Drug-Eluting Stent Sales Market Share by Type (2017-2032)
4.2 Global Drug-Eluting Stent Revenue by Type (2017-2032)
4.2.1 Global Drug-Eluting Stent Revenue by Type (2017-2023)
4.2.2 Global Drug-Eluting Stent Revenue by Type (2023-2032)
4.2.3 Global Drug-Eluting Stent Revenue Market Share by Type (2017-2032)
4.3 Global Drug-Eluting Stent Price by Type (2017-2032)
5 Segment by Application
5.1 Global Drug-Eluting Stent Sales by Application (2017-2032)
5.1.1 Global Drug-Eluting Stent Sales by Application (2017-2023)
5.1.2 Global Drug-Eluting Stent Sales by Application (2023-2032)
5.1.3 Global Drug-Eluting Stent Sales Market Share by Application (2017-2032)
5.2 Global Drug-Eluting Stent Revenue by Application (2017-2032)
5.2.1 Global Drug-Eluting Stent Revenue by Application (2017-2023)
5.2.2 Global Drug-Eluting Stent Revenue by Application (2023-2032)
5.2.3 Global Drug-Eluting Stent Revenue Market Share by Application (2017-2032)
5.3 Global Drug-Eluting Stent Price by Application (2017-2032)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Corporation Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.1.4 Boston Scientific Drug-Eluting Stent Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.2.4 Medtronic Drug-Eluting Stent Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.3.4 Abbott Drug-Eluting Stent Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Lepu Medical
6.4.1 Lepu Medical Corporation Information
6.4.2 Lepu Medical Description and Business Overview
6.4.3 Lepu Medical Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Lepu Medical Drug-Eluting Stent Product Portfolio
6.4.5 Lepu Medical Recent Developments/Updates
6.5 B. Braun Melsungen
6.5.1 B. Braun Melsungen Corporation Information
6.5.2 B. Braun Melsungen Description and Business Overview
6.5.3 B. Braun Melsungen Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.5.4 B. Braun Melsungen Drug-Eluting Stent Product Portfolio
6.5.5 B. Braun Melsungen Recent Developments/Updates
6.6 MicroPort Scientific
6.6.1 MicroPort Scientific Corporation Information
6.6.2 MicroPort Scientific Description and Business Overview
6.6.3 MicroPort Scientific Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.6.4 MicroPort Scientific Drug-Eluting Stent Product Portfolio
6.6.5 MicroPort Scientific Recent Developments/Updates
6.7 Cook Medical
6.6.1 Cook Medical Corporation Information
6.6.2 Cook Medical Description and Business Overview
6.6.3 Cook Medical Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Cook Medical Drug-Eluting Stent Product Portfolio
6.7.5 Cook Medical Recent Developments/Updates
6.8 Terumo
6.8.1 Terumo Corporation Information
6.8.2 Terumo Description and Business Overview
6.8.3 Terumo Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.8.4 Terumo Drug-Eluting Stent Product Portfolio
6.8.5 Terumo Recent Developments/Updates
6.9 Biosensors International
6.9.1 Biosensors International Corporation Information
6.9.2 Biosensors International Description and Business Overview
6.9.3 Biosensors International Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.9.4 Biosensors International Drug-Eluting Stent Product Portfolio
6.9.5 Biosensors International Recent Developments/Updates
6.10 Balton
6.10.1 Balton Corporation Information
6.10.2 Balton Description and Business Overview
6.10.3 Balton Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.10.4 Balton Drug-Eluting Stent Product Portfolio
6.10.5 Balton Recent Developments/Updates
6.11 AlviMedica Medical Technologies
6.11.1 AlviMedica Medical Technologies Corporation Information
6.11.2 AlviMedica Medical Technologies Drug-Eluting Stent Description and Business Overview
6.11.3 AlviMedica Medical Technologies Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.11.4 AlviMedica Medical Technologies Drug-Eluting Stent Product Portfolio
6.11.5 AlviMedica Medical Technologies Recent Developments/Updates
6.12 Biotronik
6.12.1 Biotronik Corporation Information
6.12.2 Biotronik Drug-Eluting Stent Description and Business Overview
6.12.3 Biotronik Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.12.4 Biotronik Drug-Eluting Stent Product Portfolio
6.12.5 Biotronik Recent Developments/Updates
6.13 Shandong JW Medical
6.13.1 Shandong JW Medical Corporation Information
6.13.2 Shandong JW Medical Drug-Eluting Stent Description and Business Overview
6.13.3 Shandong JW Medical Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.13.4 Shandong JW Medical Drug-Eluting Stent Product Portfolio
6.13.5 Shandong JW Medical Recent Developments/Updates
6.14 Sino Medical
6.14.1 Sino Medical Corporation Information
6.14.2 Sino Medical Drug-Eluting Stent Description and Business Overview
6.14.3 Sino Medical Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.14.4 Sino Medical Drug-Eluting Stent Product Portfolio
6.14.5 Sino Medical Recent Developments/Updates
6.15 Beijing AMSINO
6.15.1 Beijing AMSINO Corporation Information
6.15.2 Beijing AMSINO Drug-Eluting Stent Description and Business Overview
6.15.3 Beijing AMSINO Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2023)
6.15.4 Beijing AMSINO Drug-Eluting Stent Product Portfolio
6.15.5 Beijing AMSINO Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug-Eluting Stent Industry Chain Analysis
7.2 Drug-Eluting Stent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug-Eluting Stent Production Mode & Process
7.4 Drug-Eluting Stent Sales and Marketing
7.4.1 Drug-Eluting Stent Sales Channels
7.4.2 Drug-Eluting Stent Distributors
7.5 Drug-Eluting Stent Customers
8 Drug-Eluting Stent Market Dynamics
8.1 Drug-Eluting Stent Industry Trends
8.2 Drug-Eluting Stent Market Drivers
8.3 Drug-Eluting Stent Market Challenges
8.4 Drug-Eluting Stent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Boston Scientific
Medtronic
Abbott
Lepu Medical
B. Braun Melsungen
MicroPort Scientific
Cook Medical
Terumo
Biosensors International
Balton
AlviMedica Medical Technologies
Biotronik
Shandong JW Medical
Sino Medical
Beijing AMSINO
Medtronic
Abbott
Lepu Medical
B. Braun Melsungen
MicroPort Scientific
Cook Medical
Terumo
Biosensors International
Balton
AlviMedica Medical Technologies
Biotronik
Shandong JW Medical
Sino Medical
Beijing AMSINO
In Vitro Diagnostics Quality Control Market
Global In Vitro Diagnostics Quality Control Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Ileostomy Market
Global Ileostomy Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hypertrophic Cardiomyopathy (HCM) Therapeutics Market
Global Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Human Papillomavirus Vaccine Market
Global Human Papillomavirus Vaccine Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hospital Acquired Pneumonia Drugs Market
Global Hospital Acquired Pneumonia Drugs Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast